Rheumatology, Immunology and COVID-19: The Cytokine Storm and Open Trials
New reviews offer insights on immunotherapies
New reviews offer insights on immunotherapies
Undetectable levels achieved for nearly nine months in phase 1 trial
Successful surgery for infective endocarditis is not enough to ensure good long-term outcomes in patients with opioid use disorder, study makes clear New and different…
Cleveland Clinic Children’s will begin two clinical trials studying the use of common cancer drugs in the treatment of patients with lymphatic malformations.
Cleveland Clinic research team uncovers mechanism that transforms herpesvirus KSHV into cancer, and human enzymes that can shrink these tumors
Two-year event-free survival comparable to matched sibling donor myeloablative transplant
Innovative construct restores function after resection of softball-size chondrosarcoma
Cleveland Clinic Children’s has embarked on several new initiatives for developing medical devices and technologies specifically for pediatric patients. Cleveland Clinic Children’s ambitious goal “to…
As cancer technology evolves, Cleveland Clinic continues to explore the latest modalities to better serve patients and ensure optimal outcomes. This includes the use of…
Designed for digitization, distance health, discovery and more
When an 18-month-old patient’s symptoms worsened, pediatric otolaryngologists had to adapt quickly and coordinate care.